Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.77 and traded as low as $0.63. Medicure shares last traded at $0.63, with a volume of 4,000 shares changing hands.
Medicure Stock Performance
The company has a current ratio of 1.87, a quick ratio of 1.42 and a debt-to-equity ratio of 0.01. The stock has a market cap of $6.61 million, a PE ratio of -7.92 and a beta of 0.98. The business’s 50-day moving average price is $0.74 and its 200-day moving average price is $0.77.
Medicure (OTCMKTS:MCUJF – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $3.78 million for the quarter. Medicure had a negative return on equity of 12.72% and a negative net margin of 12.46%.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What is the Euro STOXX 50 Index?
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
